Provided by Tiger Trade Technology Pte. Ltd.

TJ DaRenTang USD

2.550
+0.0100.39%
Volume:17.80K
Turnover:44.96K
Market Cap:1.96B
PE:15.50
High:2.550
Open:2.530
Low:2.520
Close:2.540
52wk High:3.319
52wk Low:1.959
Shares:770.00M
Float Shares:421.34M
Volume Ratio:0.16
T/O Rate:0.00%
Dividend:0.71
Dividend Rate:27.96%
EPS(TTM):0.164
EPS(LYR):0.412
ROE:11.28%
ROA:5.13%
PB:2.22
PE(LYR):6.18

Loading ...

Tianjin Pharmaceutical Da Ren Tang Group issues August update on subsidiary’s bankruptcy process

SGX Filings
·
Yesterday

Tianjin Pharmaceutical Da Ren Tang shareholders approve remuneration policy and 2026 directors’ pay

SGX Filings
·
Aug 28

Tianjin Pharmaceutical Da Ren Tang Group to Host Online Briefing on Interim Results

SGX Filings
·
Aug 26

Tianjin Pharmaceutical Da Ren Tang reports status of placement proceeds and project changes

SGX Filings
·
Aug 14

Tianjin Pharmaceutical Da Ren Tang Proposes Amendments to Articles of Association

SGX Filings
·
Aug 14

Tianjin Pharmaceutical Da Ren Tang releases H1 2026 risk assessment on in-house finance arm

SGX Filings
·
Aug 14

Tianjin Pharmaceutical Unit Gets China's Nod for Diabetes Drug Registration

MT Newswires
·
Aug 10

Tianjin Pharmaceutical Da Ren Tang to Sign Warehousing Deal

MT Newswires
·
Aug 10

Tianjin Pharmaceutical Da Ren Tang receives Chinese approval for diabetes combo tablets

SGX Filings
·
Aug 07

Tianjin Pharmaceutical Da Ren Tang to Ink S$3.6 Million Related-Party Logistics Deal

SGX Filings
·
Aug 07

Tianjin Pharmaceutical Da Ren Tang Group’s Parent Lifts Stake to 43.09%

SGX Filings
·
Aug 04

Tianjin Pharmaceutical Da Ren Tang Group Issues July Update on Subsidiary Bankruptcy

SGX Filings
·
Jul 31

Tianjin Pharmaceuticals Warns of Up to 68% Plunge in H1 Profit

MT Newswires Live
·
Jul 14

Tianjin Pharmaceutical Da Ren Tang projects steep profit fall for 1H FY2026

SGX Filings
·
Jul 14

Tianjin Pharmaceutical Da Ren Tang updates on subsidiary’s bankruptcy liquidation

SGX Filings
·
Jun 30

Tianjin Pharmaceutical Da Ren Tang Group Approves FY2025 Reports, Profit Distribution and IPT Mandates at AGM

SGX Filings
·
Jun 03

Tianjin Pharmaceutical Da Ren Tang Sets Jun, 10 2026 Online Briefing for FY2025 and Q1 2026 Results

SGX Filings
·
Jun 02

Chinese State-Backed Entities to Dispose of Stake in Tianjin Pharmaceutical Da Ren Tang Unit via Public Tender

MT Newswires
·
May 20

Tianjin Pharmaceutical Da Ren Tang Group Notes Planned Sale of Upstream Shareholder

SGX Filings
·
May 19

Tianjin Pharmaceutical Da Ren Tang Group issues April update on subsidiary’s bankruptcy

SGX Filings
·
Apr 30